- Home
- NAMS vs FULT Comparison
NAMS vs FULT Comparison
Compare NAMS & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | FULT |
|---|---|---|
| Founded | 2019 | 1882 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | FULT |
|---|---|---|
| Price | $32.69 | $20.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $47.33 | $21.40 |
| AVG Volume (30 Days) | 666.3K | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $38.17 | $8.42 |
| Revenue Next Year | $573.62 | $5.63 |
| P/E Ratio | ★ N/A | $10.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.06 | $14.33 |
| 52 Week High | $42.00 | $22.99 |
Technical Indicators
Market Signals| Indicator | NAMS | FULT |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 45.64 |
| Support Level | $30.34 | $16.93 |
| Resistance Level | $37.43 | $21.01 |
| Average True Range (ATR) | 1.82 | 0.71 |
| MACD | -0.12 | -0.23 |
| Stochastic Oscillator | 5.46 | 30.42 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.